[ASND] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
16-Nov-2017
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -0.88%
YoY- -107.78%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 535 2,507 10,515 280 1,043 1,977 2,826 -24.20%
PBT -138,982 -80,400 -32,066 -34,361 -16,426 -12,249 -5,803 69.69%
Tax -17 -38 -88 -186 22 -254 -765 -46.94%
NP -138,965 -80,362 -31,978 -34,175 -16,448 -11,995 -5,038 73.73%
Tax Rate - - - - - - - -
Total Cost 139,500 82,869 42,493 34,455 17,491 13,972 7,864 61.42%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -25,974.77 -3,205.50 -304.12 -12,205.36 -1,576.99 -606.73 -178.27 129.21%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -2.60 -1.68 -0.76 -0.92 -0.51 -0.48 -0.24 48.69%
EPS Diluted -2.58 -1.67 -0.74 -0.88 -0.51 -0.48 -0.21 51.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.